Erlotinib added to bevacizumab as maintenance therapy and health-related quality of life in patients with metastatic colorectal cancer: results of the GERCOR DREAM phase III trial
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Erlotinib added to bevacizumab as maintenance therapy and health-related quality of life in patients with metastatic colorectal cancer: results of the GERCOR DREAM phase III trial |
| Type de publication | Journal Article |
| Year of Publication | 2016 |
| Auteurs | Anota A, Vernerey D, Tournigand C, Chibaudel B, Samson B, Scheithauer W, Brusquant D, Andre T, de Gramont A, Bonnetain F |
| Journal | QUALITY OF LIFE RESEARCH |
| Volume | 25 |
| Pagination | 112 |
| Date Published | OCT |
| Type of Article | Meeting Abstract |
| ISSN | 0962-9343 |